Implementation of Criteria to Predict Medication-Related Readmissions within High-Risk Patients

From the 2018 HVPAA National Conference

Belinda Mang (Parkland Health & Hospital System), Kristin S. Alvarez (Parkland Health and Hospital System), Kristy Vo (Parkland Health & Hospital System), Kathryn Johnson (Texas Tech University Health Sciences Center)

Background

The Transitional Care Unit (TCU) at Parkland is a program identifying high-risk patients to improve patient access, promote engagement, and reduce 30-day readmissions. A nurse case manager selects patients utilizing predictive analytics. A pharmacist performs a comprehensive assessment of medications at discharge, reconciles discrepancies or problems, and provides counseling.

Objectives

To balance the value of this service with resource limitations in a large safety-net hospital, a stratification was developed to classify patients as high-, moderate-, or low-risk for medication-related readmissions, which subsequently correlated with the intensity of pharmacist intervention. The aim of this review is to characterize 30-day medication-related readmissions in TCU patients receiving pharmacist intervention.

Methods

We undertook a retrospective chart review of patients who received pharmacist intervention post-implementation between October and December 2017. Readmissions were reviewed for primary diagnosis, contribution of medication-related problems, and readmission setting (inpatient, observation, or emergency department/urgent care).

Results

Three-hundred and sixty-three patients were eligible with most patients categorized as high-risk (68.3%) and receiving intensive pharmacist intervention, followed by moderate- (19.3%) and low-risk (12.4%). Overall, 42 (11.6%) were readmitted within 30 days and 21 were associated with a medication, resulting in a medication-related readmission rate of 5.8%. This was primarily driven by the high-risk (6.9%) group as compared to moderate-risk (4.3%) and low-risk (2.2%) groups, with 66.7% related to noncompliance. No discernible trend was seen in observation and emergency department/urgent care revisits with 2.4%, 1.4%, and 2.2% medication-related revisit rates in the high-, moderate-, and low-risk groups, respectively, despite an all-cause revisit rate of 9.1%.

Conclusion

Our findings suggest that risk categorization may predict medication-related readmissions as observed by down-trending readmission rates. While greater readmissions were observed in the high-risk group, no control group was available to compare the impact of pharmacist intervention.

Implications for the Patient

This data provides a foundation to continue developing more robust stratification processes, ultimately providing targeted pharmaceutical interventions in a resource-appropriate manner to achieve and sustain improved patient outcomes.

Click here to register for the 2022 Architecture of High Value Health Care National Conference!

What are academic medical centers across the country doing to improve healthcare value?

Value improvement guides: Published reviews in JAMA Internal Medicine coauthored by experienced faculty from multiple leading medical centers, with safety outcomes data and an implementation blue print.

Review article detailing 25 labs to refine for high value quality improvement | July 2020

MAVEN campaign: Free 4 year high value care curriculum online.

Join the Alliance! Membership is free with institutional approval and commitment to improving value in your medical center.

Learn more about HVPAA on Health Affairs Blog